Phase IV Randomized Study of Two Dose Levels of Targetin

Project: Research project

Project Details

Description

Phase IV Randomized Study of Two Dose Levels of Targetin Capsules in Patients with Refractory Cutaneous T-Cell Lymphoma
StatusFinished
Effective start/end date3/18/1012/31/20

Funding

  • EISAI MEDICAL RESEARCH INC.